LifeMD, Inc. — Director's Dealing 2023

Feb 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-02-09

Reporting Person: LAROVERE JOAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-09	Common Stock	A	75000	—	Acquired	75000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-09	Stock Option (Right to Buy)	$1.89	A	37500	Acquired	2028-02-09	Common Stock (37500)	Direct

Footnotes

F1: Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 75,000 restricted shares, with 37,500 vesting immediately and 37,500 shares vesting on the two year anniversary of the date of grant.

F2: The option vests on the two year anniversary of the date of grant.